IRIS
PICCO, AGNESE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.956
AS - Asia 726
NA - Nord America 428
SA - Sud America 51
AF - Africa 23
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.188
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.815
US - Stati Uniti d'America 408
SG - Singapore 321
CN - Cina 175
VN - Vietnam 145
FR - Francia 61
BR - Brasile 29
FI - Finlandia 21
HK - Hong Kong 16
NL - Olanda 16
AR - Argentina 14
JP - Giappone 13
DE - Germania 11
ID - Indonesia 8
IQ - Iraq 8
MX - Messico 8
GB - Regno Unito 7
IN - India 7
BD - Bangladesh 6
CA - Canada 6
DZ - Algeria 5
IE - Irlanda 5
CH - Svizzera 4
TN - Tunisia 4
ZA - Sudafrica 4
RU - Federazione Russa 3
TW - Taiwan 3
UZ - Uzbekistan 3
AT - Austria 2
AU - Australia 2
BE - Belgio 2
EC - Ecuador 2
ET - Etiopia 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
MY - Malesia 2
PH - Filippine 2
PY - Paraguay 2
SA - Arabia Saudita 2
SE - Svezia 2
UA - Ucraina 2
AZ - Azerbaigian 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ES - Italia 1
GF - Guiana Francese 1
JO - Giordania 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MM - Myanmar 1
MN - Mongolia 1
NC - Nuova Caledonia 1
NP - Nepal 1
OM - Oman 1
PK - Pakistan 1
PL - Polonia 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SL - Sierra Leone 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 8.188
Salva come PNG Salva come JPEG
Città #
Genova 3.971
Genoa 1.668
Rapallo 661
Vado Ligure 467
Singapore 158
San Jose 100
Ashburn 69
Ho Chi Minh City 55
Lauterbourg 50
Beijing 41
Hanoi 27
Helsinki 20
Bordighera 17
Hong Kong 15
New York 13
Council Bluffs 12
Oegstgeest 12
Santa Clara 12
Frankfurt am Main 10
Tokyo 10
Da Nang 8
Rome 7
Mexico City 6
Biên Hòa 5
Dallas 5
Dublin 5
Haiphong 5
Orem 5
Tianjin 5
Atlanta 4
Chicago 4
Houston 4
Los Angeles 4
Zurich 4
Amsterdam 3
Brooklyn 3
Chennai 3
Tashkent 3
Addis Ababa 2
Algiers 2
Allentown 2
Brasília 2
Brussels 2
Cantalupo Ligure 2
Cardiff 2
Ciudad del Este 2
Correggio 2
Dammam 2
Denver 2
Erbil 2
Francavilla Fontana 2
Greenville 2
Hải Dương 2
Johannesburg 2
Mendoza 2
Montreal 2
Nairobi 2
Ninh Bình 2
Orlando 2
Paris 2
Philadelphia 2
Poplar 2
Shanghai 2
Staten Island 2
Sydney 2
São Paulo 2
Thái Nguyên 2
Toronto 2
Washington 2
Acarigua 1
Ahmedabad 1
Alta Gracia 1
Amman 1
Aurora 1
Aïn Oussera 1
Baghdad 1
Baku 1
Bananal 1
Bandung 1
Bangkinang 1
Bangkok 1
Bari 1
Barueri 1
Basra 1
Belgrade 1
Belém 1
Bergamo 1
Boardman 1
Bogotá 1
Bologna 1
Bonito 1
Boydton 1
Bridgeview 1
Brockton 1
Buffalo 1
Bắc Ninh 1
Capão da Canoa 1
Capão do Cipó 1
Casablanca 1
Castries 1
Totale 7.564
Salva come PNG Salva come JPEG
Nome #
A normative study of the Italian printed word version of the free and cued selective reminding test 228
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 214
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 213
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort 207
Amyloid positron emission tomography and cognitive reserve. 202
Neuroimaging findings in mild cognitive impairment 201
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 194
Parkinson’s Disease Sleep Scale 2: application in an Italian population 187
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease. 186
Nigro-caudate dopaminergic deafferentation: A marker of REM sleep behavior disorder? 179
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 178
Early identification of MCI converting to AD: a FDG PET study 173
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 172
Brain Functional Network in Alzheimer’s Disease: Diagnostic Markers for Diagnosis and Monitoring 169
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 169
Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects 165
What predicts cognitive decline in de novo Parkinson's disease? 163
Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD 162
Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. 162
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study 157
Correlation between Doppler velocities and duplex ultrasound carotid cross-sectional percent stenosis. 155
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 151
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 148
The role of the serotonergic system in REM sleep behavior disorder 148
Biomarkers validation in Alzheimer’s Disease and related pathologies 148
Functional imaging in pre-motor Parkinson's disease 147
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes 147
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 144
Metabolic correlates of rey auditory verbal learning test in elderly subjects with memory complaints 142
Screening of Early and Late Onset Alzheimer's Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy. 141
Clinical validity of presynaptic dopaminergic imaging with (123)I-ioflupane and noradrenergic imaging with (123)I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework 139
Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework 136
Direct correlation between cardiac and striatal F-18-DOPA uptake in de novo Parkinson's disease 135
Cortical structural covariance of nigro.striatal degeneration in dementia with Lewy bodies 133
Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study 133
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 130
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework 129
Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study 129
What predicts future cognitive decline in de novo Parkinson’s disease (PD)? 127
Amygdalar nuclei and hippocampal subfields on MRI: test-retest reliability of automated volumetry across different MRI sites and vendors 126
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers 124
Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC) 122
Orbitofrontal (18) F-DOPA Uptake and Movement Preparation in Parkinson's Disease. 118
Neuroimaging Findings in Mild Cognitive Impairment 118
Dopaminergic Activity and Cognitive Function in de novo Parkinson Disease patients: an 18F-DOPA PET/CT study 117
Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects 117
Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly 116
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 113
Lupus nephritis and Cyclic Vomiting Syndrome: a case report. 108
Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques 107
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease 98
Studio dell’attività serotoninergica troncoencefalica nel disturbo comportamentale del sonno REM. 97
Functional neuroimaging in de novo Parkinson's disease with REM sleep behaviour disorder 93
Nigrocaudate dopaminergic impairment predict future cognitive decline in de novo parkinson’s disease (PD) 93
Resting metabolic connectivity in Alzheimer's disease 85
White Matter Hyperintensities are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 81
null 70
PSYCHOMETRIC PROPERTIES OF THE ITALIAN VERSION OF RESILIENCE SCALE IN ADULTS AND ELDERLY HEALTHY SUBJECTS 62
Totale 8.308
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.357
article - articoli 23.826
book - libri 0
conference - conferenze 2.038
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.068
Totale 54.289
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202146 0 0 0 0 0 0 0 0 0 0 0 46
2021/2022703 23 20 52 81 23 67 31 167 50 62 22 105
2022/2023753 62 62 14 83 106 121 0 64 126 11 98 6
2023/2024422 20 42 8 59 39 88 18 37 19 5 19 68
2024/20251.130 35 79 18 78 162 131 107 169 54 48 109 140
2025/20261.920 287 46 93 140 293 165 312 83 196 163 98 44
Totale 8.308